Literature DB >> 10588655

Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells.

J S Park1, S Carter, D B Reardon, R Schmidt-Ullrich, P Dent, P B Fisher.   

Abstract

We investigated the role of the cdk inhibitor protein p21(Cip-1/WAF1/MDA6) (p21) in the ability of MAPK pathway inhibition to enhance radiation-induced apoptosis in A431 squamous carcinoma cells. In carcinoma cells, ionizing radiation (2 Gy) caused both primary (0-10 min) and secondary (90-240 min) activations of the MAPK pathway. Radiation induced p21 protein expression in A431 cells within 6 h via secondary activation of the MAPK pathway. Within 6 h, radiation weakly enhanced the proportion of cells in G(1) that were p21 and MAPK dependent, whereas the elevation of cells present in G(2)/M at this time was independent of either p21 expression or MAPK inhibition. Inhibition of the MAPK pathway increased the proportion of irradiated cells in G(2)/M phase 24-48 h after irradiation and enhanced radiation-induced apoptosis. This correlated with elevated Cdc2 tyrosine 15 phosphorylation, decreased Cdc2 activity, and decreased Cdc25C protein levels. Caffeine treatment or removal of MEK1/2 inhibitors from cells 6 h after irradiation reduced the proportion of cells present in G(2)/M phase at 24 h and abolished the ability of MAPK inhibition to potentiate radiation-induced apoptosis. These data argue that MAPK signaling plays an important role in the progression/release of cells through G(2)/M phase after radiation exposure and that an impairment of this progression/release enhances radiation-induced apoptosis. Surprisingly, the ability of irradiation/MAPK inhibition to increase the proportion of cells in G(2)/M at 24 h was found to be dependent on basal p21 expression. Transient inhibition of basal p21 expression increased the control level of apoptosis as well as the abilities of both radiation and MEK1/2 inhibitors to cause apoptosis. In addition, loss of basal p21 expression significantly reduced the capacity of MAPK inhibition to potentiate radiation-induced apoptosis. Collectively, our data argue that MAPK signaling and p21 can regulate cell cycle checkpoint control in carcinoma cells at the G(1)/S transition shortly after exposure to radiation. In contrast, inhibition of MAPK increases the proportion of irradiated cells in G(2)/M, and basal expression of p21 is required to maintain this effect. Our data suggest that basal and radiation-stimulated p21 may play different roles in regulating cell cycle progression that affect cell survival after radiation exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588655      PMCID: PMC25755          DOI: 10.1091/mbc.10.12.4231

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  72 in total

1.  Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

Authors:  T Putz; Z Culig; I E Eder; C Nessler-Menardi; G Bartsch; H Grunicke; F Uberall; H Klocker
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

2.  Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.

Authors:  L E Johannessen; S L Knardal; I H Madshus
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Ionizing radiation-induced MEK and Erk activation does not enhance survival of irradiated human squamous carcinoma cells.

Authors:  J A Bonner; B T Vroman; T J Christianson; L M Karnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-11-01       Impact factor: 7.038

4.  Enforced CDK4 expression in a hematopoietic cell line confers resistance to the G1 arrest induced by ionizing radiation.

Authors:  M F Reed; V F Liu; M H Ladha; K Ando; J D Griffin; D T Weaver; M E Ewen
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

Review 5.  Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.

Authors:  S P Chellappan; A Giordano; P B Fisher
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

6.  The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.

Authors:  K L Auer; J Contessa; S Brenz-Verca; L Pirola; S Rusconi; G Cooper; A Abo; M P Wymann; R J Davis; M Birrer; P Dent
Journal:  Mol Biol Cell       Date:  1998-03       Impact factor: 4.138

7.  Antisense blockade of p21/WAF1 decreases radiation-induced G2 arrest in esophageal squamous cell carcinoma.

Authors:  D A Rigberg; T A Blinman; F S Kim; M A Cole; D W McFadden
Journal:  J Surg Res       Date:  1999-01       Impact factor: 2.192

8.  A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.

Authors:  A Blasina; I V de Weyer; M C Laus; W H Luyten; A E Parker; C H McGowan
Journal:  Curr Biol       Date:  1999-01-14       Impact factor: 10.834

9.  Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice.

Authors:  K L Auer; J S Park; P Seth; R J Coffey; G Darlington; A Abo; M McMahon; R A Depinho; P B Fisher; P Dent
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.

Authors:  S Ruan; M F Okcu; R C Pong; M Andreeff; V Levin; J T Hsieh; W Zhang
Journal:  Clin Cancer Res       Date:  1999-01       Impact factor: 12.531

View more
  8 in total

1.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

2.  Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma.

Authors:  Gang Niu; Xilin Sun; Qizhen Cao; Donald Courter; Albert Koong; Quynh-Thu Le; Sanjiv Sam Gambhir; Xiaoyuan Chen
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

4.  Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation.

Authors:  J J Tang; C Shen; Y J Lu
Journal:  Mol Cell Biochem       Date:  2006-08-15       Impact factor: 3.396

Review 5.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Authors:  Hari K Koul; Mantu Pal; Sweaty Koul
Journal:  Genes Cancer       Date:  2013-09

6.  The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer.

Authors:  Xin Jin; Qingqing Mo; Yu Zhang; Yue Gao; Yuan Wu; Jing Li; Xing Hao; Ding Ma; Qinglei Gao; Pingbo Chen
Journal:  Cancer Biol Ther       Date:  2016-05-03       Impact factor: 4.742

7.  MytiLec, a Mussel R-Type Lectin, Interacts with Surface Glycan Gb3 on Burkitt's Lymphoma Cells to Trigger Apoptosis through Multiple Pathways.

Authors:  Imtiaj Hasan; Shigeki Sugawara; Yuki Fujii; Yasuhiro Koide; Daiki Terada; Naoya Iimura; Toshiyuki Fujiwara; Keisuke G Takahashi; Nobuhiko Kojima; Sultana Rajia; Sarkar M A Kawsar; Robert A Kanaly; Hideho Uchiyama; Masahiro Hosono; Yukiko Ogawa; Hideaki Fujita; Jiharu Hamako; Taei Matsui; Yasuhiro Ozeki
Journal:  Mar Drugs       Date:  2015-12-14       Impact factor: 5.118

8.  Nephronectin mediates p38 MAPK-induced cell viability via its integrin-binding enhancer motif.

Authors:  Jimita Toraskar; Synnøve N Magnussen; Konika Chawla; Gunbjørg Svineng; Tonje S Steigedal
Journal:  FEBS Open Bio       Date:  2018-11-15       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.